Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: Prophylaxis and treatment controversies
Open Access
- 1 January 2012
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Transplantation
- Vol. 2 (2), 27-34
- https://doi.org/10.5500/wjt.v2.i2.27
Abstract
Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome, is a major complication of hematopoietic stem cell transplantation and it carries a high mortality. Prophylaxis for hepatic VOD is commonly given to transplant recipients from the start of conditioning through the early weeks of transplant. However, high quality evidence from randomized controlled trials is scarce with small sample sizes and the trials yielded conflicting results. Although various treatment options for hepatic VOD are available, most have not undergone stringent evaluation with randomized controlled trial and therefore it remains uncertain which treatment offers real benefit. It remains controversial whether VOD prophylaxis should be given, which prophylactic therapy should be given, who should receive prophylaxis, and what treatment should be offered once VOD is established.Keywords
This publication has 101 references indexed in Scilit:
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding TrialTransplantation and Cellular Therapy, 2010
- Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeTransplantation and Cellular Therapy, 2010
- Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantationBlood, 2008
- Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparinBone Marrow Transplantation, 2001
- Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantationBone Marrow Transplantation, 1999
- Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Parenteral glutamine protects hepatic function during bone marrow transplantationBone Marrow Transplantation, 1998
- Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantationBone Marrow Transplantation, 1997
- Alteplase for hepatic veno-occlusive disease after bone-marrow transplantationThe Lancet, 1992
- Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantationThe Lancet, 1992